ClinicalTrials.govpublic full text
Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
cancer, breakthrough pain, sickle cell, severe burns, children, adolescents, analgesia, sickle cell disease, non-cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 855058
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.